Vitiligo - Pipeline Review, H1 2017, provides an overview of the Vitiligo pipeline landscape. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=992895 Vitiligo is a condition in which skin loses melanin, the pigment that determines the color of skin, hair and eyes. Symptoms include premature whitening or graying of the hair on scalp, eyelashes, eyebrows or beard, loss of color in the tissues that line the inside of mouth and loss of or change in color of the inner layer of eye. Treatment includes corticosteroid therapy, immunomodulators and surgery. Companies of Vitiligo Pipeline, H1 2017 main companies are Aclaris Therapeutics Inc, Biocon Ltd, Bristol-Myers Squibb Company, Celgene Corp, Clinuvel Pharmaceuticals Ltd, Incyte Corp. Vitiligo - Drug Profiles - abatacept, afamelanotide, apremilast, ATI-50001, ATI-50002, itolizumab, ruxolitinib phosphate. Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=992895 (This report is available at upto 25% Discount till June 02nd 2017.) Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Vitiligo . The pipeline guide reviews pipeline therapeutics for Vitiligo by companies and universities/research institutes based on information derived from company and industryspecific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Vitiligo therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Vitiligo therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Vitiligo
Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=992895 List of Tables Number of Products under Development for Vitiligo, H1 2017 Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Vitiligo - Pipeline by Amorepacific Corp, H1 2017 Vitiligo - Pipeline by BioPharmX Inc, H1 2017 Vitiligo - Pipeline by Cutanea Life Sciences Inc, H1 2017 Vitiligo - Pipeline by ELORAC Inc, H1 2017 Vitiligo - Pipeline by Foamix Pharmaceuticals Ltd, H1 2017 Vitiligo - Pipeline by Hovione FarmaCiencia SA, H1 2017 Vitiligo - Pipeline by Promius Pharma LLC, H1 2017 Vitiligo - Pipeline by Sol-Gel Technologies Ltd, H1 2017 Vitiligo - Dormant Projects, H1 2017 Vitiligo - Discontinued Products, H1 2017 About Us: ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.